Osivax

Developer of vaccines against constantly mutating pathogens

placeLyon, Auvergne Rhone Alpes, France calendar_todayFounded 2017 groups40 employees language osivax.com

Innovation

9 patent families (4 granted) — focus: Human necessities, Chemistry & metallurgy; filing pace steady. Cited 176 times.

YearFilings
20121
20181
20193
20221
20235
20245
20252

Social engagement

Social engagement: 8.1K social following, 10 posts in the last 12 months — below the industry typical range.

Investor mix

12 investors on record; lead investors include Noshaq, EIC Fund.

Investor typeCountShare
Venture capital542%
Accelerator & incubator18%
Bank & private debt18%
Other / undisclosed542%

Hiring activity

Hires occasionally

1 role tracked across 1 of the last 12 months

24 Apr 2026 · Chargé(e) de Biochimie analytique, Chargé(e) de Purification des Protéines · Lyon

Based on job postings tracked across public sources.

Recent activity

22 May 2026
Event
France 2030
19 May 2026
Event
BioEquity Europe 2026
28 Apr 2026
Event
BioEquity Europe 2026
Coming soon